Hybrid MgAl-Layered Double Hydroxide/Chondroitin Sulfate Nanoparticles for CD44-Targeted Cancer Therapy
Research Journal of Biotechnology · 31.07.2026 · 21 (9) · 1
DOI: 10.25303/219rjbt01014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research Journal of Biotechnology, online erschienen am 31.07.2026. Verfasst von Hoang Minh Quy Tran und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Layered double hydroxide (LDH) materials have emerged as promising nanocarriers for cancer drug delivery due to their biocompatibility, large surface area and high drug-loading capacity. However, their lack of targeting ability remains a limitation. In this study, a hybrid system combining MgAl-LDH and chondroitin sulfate sodium (CSS), termed LCS, was fabricated via an in situ method and the influence of CSS dosage and the time of CSS addition on the characteristics of the LCS were investigated. Among the tested conditions, the LCS-B0.5 sample exhibited the most favorable characteristics including a narrow size distribution and enhanced methyl orange (MO) loading efficiency of 39.1%, surpassing that of pristine LDHs. Cytocompatibility assessment using 3-(4,5- dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) assay on L929 fibroblasts revealed >90% cell viability at all tested concentrations. Moreover, LCS-B0.5 demonstrated a prolonged MO release profile over 48 hours under physiological conditions, supporting its potential for minimizing premature drug leakage before the carrier reaches the tumor site. The combination of surface CSS integration as a CD44-targeting ligand, excellent cytocompatibility, high drug-loading efficiency and sustained release behavior underscores the potential of LCS as an effective nanocarrier platform for targeted cancer therapy.
Zitieren
APA
Tran, H. M. Q., Tran, Q. M., & Tu, T. T. A. (2026). Hybrid MgAl-Layered Double Hydroxide/Chondroitin Sulfate Nanoparticles for CD44-Targeted Cancer Therapy. Research Journal of Biotechnology, 21(9), 1. https://doi.org/10.25303/219rjbt01014
Vancouver
Tran HMQ, Tran QM, Tu TTA. Hybrid MgAl-Layered Double Hydroxide/Chondroitin Sulfate Nanoparticles for CD44-Targeted Cancer Therapy. Research Journal of Biotechnology. 2026;21(9):1. doi:10.25303/219rjbt01014
BibTeX
@article{Tran2026,
author = {Tran, Hoang Minh Quy and Tran, Quang Minh and Tu, Thi Tram Anh},
title = {Hybrid MgAl-Layered Double Hydroxide/Chondroitin Sulfate Nanoparticles for CD44-Targeted Cancer Therapy},
journal = {Research Journal of Biotechnology},
year = {2026},
volume = {21},
number = {9},
pages = {1},
doi = {10.25303/219rjbt01014}
}
EUVIMED